Cargando…
Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis
Tumor metastasis is the most common cause of death and poor prognosis for cancer patients. Therapeutics that prevent tumor metastasis are the key to prolonging the lifespan of cancer patients. Cancer stem cells are believed to be critical in the metastatic process. Recently, drug screening for cance...
Autores principales: | Lu, Meiling, Li, Jinghua, Luo, Zaili, Zhang, Shuai, Xue, Shaobo, Wang, Kesheng, Shi, Yan, Zhang, Cunzhen, Chen, Haiyang, Li, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482370/ https://www.ncbi.nlm.nih.gov/pubmed/26124671 http://dx.doi.org/10.2147/OTT.S77373 |
Ejemplares similares
-
Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model
por: YIN, TAO, et al.
Publicado: (2015) -
A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression
por: Chen, Haiyang, et al.
Publicado: (2015) -
Effect of Thioridazine on Erythrocytes
por: Lang, Elisabeth, et al.
Publicado: (2013) -
CD133/Prominin-1-Mediated Autophagy and Glucose Uptake Beneficial for Hepatoma Cell Survival
por: Chen, Haiyang, et al.
Publicado: (2013) -
Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
por: Jin, Xun, et al.
Publicado: (2016)